Published Date: 3-Feb-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Burn Ointment Market, published by KBV research, The Global Burn Ointment Market size is expected to reach $1.1 billion by 2026, rising at a market growth of 5.7% CAGR during the forecast period.
The silver-based ointment segment is expected to show the fast growth over the forecast period. This ointment is useful in the treatment and cure of second and third-degree burn wound infections. It has antibacterial and antimicrobial properties. The silver-based ointments that are available in the market are Silver nitrate, Silver foams, Flammacerium, Silver sulfadiazine, Aquacel-Ag, Silvercel, Acticoat 7, and Silver amniotic membrane.
The minor burn category had the highest revenue share in the market in 2019. This type of burn damage the outermost skin layer. The minor burn is any burn that is less than 10.0% of the Total Body Surface Area (TBSA). Nearly 1.2 million people in the US is affected by minor burn each year. Thus, an increasing number of minor burn cases is likely to boost the growth of this segment over the forecast period.
The North America market dominated the Global Burn Ointment Market by Region in 2019. In Asia Pacific, the market is predicted to show the fastest growth over the forecast period. According to WHO, the increasing incidences of blaze wounds that require immediate medical attention is almost 20 times more in the Western Pacific region as compared to America. The rise in the incidence of blaze wounds is one of the major factors that is boosting the market in this region.
Full Report: https://www.kbvresearch.com/burn-ointment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
By Depth of Burn
By End Use
Unique Offerings from KBV Research